跳至主要内容
临床试验/NCT05233527
NCT05233527进行中(未招募)不适用

Observational, Retrospective, Monocentric Clinical Study on the Safety of Novosyn® Quick in Women With a Spontaneous Vaginal Delivery Who Required an Indicated Episiotomy

Aesculap AG2 个研究点 分布在 1 个国家目标入组 229 人开始时间: 2024年5月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Aesculap AG
入组人数
229
试验地点
2
主要终点
Wound dehiscence rate

研究概览

简要总结

Retrospective, monocentric clinical study on the clinical performance of Novosyn® Quick in patients undergoing episiotomy closure.

详细描述

The study design is a retrospective, consecutive series of women with a spontaneous vaginal delivery who required an indicated episiotomy with Novosyn® Quick between the period January 2020 - December 2020 at Hospital General de Catalunya.

All women treated with Novosyn® Quick between January 2020 - December 2020 at the Hospital General de Catalunya will be analyzed. The investigator team will access medical records for the cohort of patients identified.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women who underwent an indicated episiotomy between January 2020 - December 2020 at the Hospital General de Catalunya (Sant Cugat del Vallès, Spain) and received Novosyn® Quick

排除标准

  • No exclusion criteria have been set

结局指标

主要结局

Wound dehiscence rate

时间窗: up to 1 month postpartum

A dehiscence of the wound which needs surgical treatment with re-closure.

次要结局

  • Rectovaginal fistula(up to 1 month postpartum)
  • Long-term perineal pain (VAS)(up to 1 month postpartum)
  • Rate of Re-suturing(up to 1 month postpartum)
  • Surgical Site Infection rate(up to 1 month postpartum)
  • Abscess formation(up to 1 month postpartum)
  • Short-term Pain in daily living (VAS)(24-48 hours postpartum)
  • Hematoma(up to 1 month postpartum)
  • Short-term perineal pain (VAS)(after 48 hours postpartum)
  • Rate of Suture removal due to wound problems(up to 1 month postpartum)
  • Bleeding(up to 1 month postpartum)
  • Long-term Pain in daily living (VAS)(up to 1 month postpartum)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Novosyn® Quick in Patients Undergoing Episiotomy... | 临床试验